Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,010 | Dovepress* | 13,297+ | 1,674 | 14,971 | |
| PubMed Central* | 4,713 | 1,192 | 5,905 | ||
| Totals | 18,010 | 2,866 | 20,876 | ||
| *Since 17 April 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar